The attenuation of these increases by F13B suggests that it negatively regulates VEGF-induced signaling, particularly in the AKT/mTOR pathway, potentially reducing angiogenesis and metastasis in HCC. The gene discussed is VEGFA; the disease is hepatocellular carcinoma.